PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPascolizumab
Pascolizumab
Pascolizumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against interleukin-4.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
38 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atopic dermatitisD003876EFO_0000274L20113127
DermatitisD003872—L30.9113127
AsthmaD001249EFO_0000270J45—1—315
Nasal polypsD009298—J33———2—2
EczemaD004485—L30.9——11—2
RhinosinusitisD000096825—————1—1
HypersensitivityD006967EFO_0003785T78.40———1—1
HypercholesterolemiaD006937—————1—1
Hyperlipoproteinemia type iiD006938EFO_0004911E78.00———1—1
SinusitisD012852EFO_0007486J32———1—1
Show 1 more
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
UrticariaD014581EFO_0005531L50—2——13
Allergic rhinitisD065631—J30.912———3
RhinitisD012220EFO_0008521J3112———3
Chronic urticariaD000080223—L50.8—1——12
LeukemiaD007938—C9522———2
Myelodysplastic syndromesD009190—D4622———2
LymphomaD008223—C85.922———2
PreleukemiaD011289——22———2
SyndromeD013577——11——12
AngioedemaD000799EFO_0005532T78.3—1———1
Show 23 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.91————1
Prediabetic stateD011236EFO_1001121R73.031————1
Body weightD001835EFO_0004338—1————1
Metabolic syndromeD024821EFO_0000195E88.8101————1
Ideal body weightD056865——1————1
KeratoconjunctivitisD007637—H16.21————1
Allergic conjunctivitisD003233EFO_0007141H10.441————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Autonomic nervous system diseasesD001342EFO_0009532G90————11
DiseaseD004194EFO_0000408R69————11
Duchenne muscular dystrophyD020388EFO_0000429—————11
Muscular dystrophiesD009136EFO_0000757G71.0————11
Systemic sclerodermaD012595EFO_0000717M34————11
Localized sclerodermaD012594EFO_1001361L94.0————11
Diffuse sclerodermaD045743EFO_0000404—————11
InflammationD007249MP_0001845—————11
Periodontal diseasesD010510—K05.6————11
PeriodontitisD010518EFO_0000649K05.3————11
Show 13 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePascolizumab
INNpascolizumab
Description
Pascolizumab (humanized mab)
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL2108119
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDN1IOA09R6A (ChemIDplus, GSRS)
Target
Agency Approved
IL4
IL4
Organism
Homo sapiens
Gene name
IL4
Gene synonyms
NCBI Gene ID
Protein name
interleukin-4
Protein synonyms
B cell growth factor 1, B-cell stimulatory factor 1, B_cell stimulatory factor 1, Binetrakin, BSF-1, Lymphocyte stimulatory factor 1, Pitrakinra
Uniprot ID
Mouse ortholog
Il4 (16189)
interleukin-4 (P07750)
Alternate
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 105 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use